Long-term Safety and Efficacy of Roflumilast Cream 0.3% in Adult Patients With Chronic Plaque Psoriasis: Results From a 52-Week, Phase 2b Open-Label Study. J of Skin. 2021;5(6):s44. doi:10.25251/skin.5.supp.44